Knee Disease
Conditions
Brief summary
Randomized controlled single blind trial for the evaluation of the treatment of the surgical wound healing process with Platelet-Rich-Fibrin compared to the gold standard (without Platelet-Rich-Fibrin) in patients undergoing knee replacement.
Interventions
total knee replacement surgery
Sponsors
Study design
Eligibility
Inclusion criteria
* Males or females undergoing a total knee prosthesis. * Willingness and ability to comply with the study procedures and visit schedules and ability to follow verbal and written instructions. * Hb \> 11 g/dl; Platelet value \> 150.000 plt/mmc; * Patients with non clinical alteration of ECG; * Signature of informed consent;
Exclusion criteria
* Patients incapable of understanding and of wanting; * Systemic disorders such as diabetes, rheumatic diseases; * Patients with malignancy; * Thyroid metabolic disorders ; * Abuse of alcohol, drugs and pharmaceutical drugs * Body mass index \> 40;
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| clinical improvement of the healing process | 2 weeks | Clinical improvement of the healing process, assessed by application of the Hollander Wound Evaluation Scales at 2 weeks of follow up |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Dermatology life quality | 3 days, 15 days and 1 month | Dermatology life quality index improvement at 3 days, 15 days and 1 month |
Countries
Italy